Evidence map›Paper›PMID 20377338›Full record

ReviewExpert review of anti-infective therapy2010

Role of the gut microbiota in defining human health.

Kei E Fujimura, Nicole A Slusher, Michael D Cabana, Susan V Lynch

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of anti-infective therapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed, 2 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 2 syntheses or guidelines pooled it, 396 citations in OpenAlex.

  1. Pediatrics Consequences of Caesarean Section-A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2020
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kei E FujimuraColitis and Crohn's Disease Center, Gastroenterology Division, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
Nicole A Slusher
Michael D Cabana
Susan V Lynch
University of California, San Francisco · US

Funding

SFSU MBRS - RISER25GM059298 · NIGMS · SAN FRANCISCO STATE UNIVERSITY · PI BAIRD, TEASTER T, BAYLISS, FRANK T · 1999 to 2021
$21.0M
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) StudyU01HL098964 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, LAURENCE · 2009 to 2013
$3.9M
Resequencing microarray for rapid detection & antimicrobial resistance profilingU01AI075410 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LYNCH, SUSAN VERONICA · 2007 to 2011
$3.5M
The Human Microbiome in Pediatric Abdominal Pain and Intestinal InflammationUH3DK083990 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI VERSALOVIC, JAMES · 2010 to 2012
$3.3M
Trial of Infant Probiotic Exposure on Developing AsthmaR01HL080074 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CABANA, MICHAEL D · 2004 to 2008
$2.4M
The Human Microbiome in Pediatric Abdominal Pain and Intestinal InflammationUH2DK083990 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI VERSALOVIC, JAMES · 2009 to 2009
$755k
Probiotic Outcomes in Enteric Microflora (POEM) StudyR21AT004732 · NCCIH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CABANA, MICHAEL D · 2009 to 2010
$374k
NCCIH NIH HHS AT004732NCCIH NIH HHS R21 AT004732NHLBI NIH HHS HL080074NHLBI NIH HHS HL098964NHLBI NIH HHS R01 HL080074NHLBI NIH HHS U01 HL098964NIAID NIH HHS AI075410NIAID NIH HHS U01 AI075410NIDDK NIH HHS DK083990NIDDK NIH HHS UH2 DK083990NIDDK NIH HHS UH3 DK083990NIGMS NIH HHS 5R25GM-059298NIGMS NIH HHS R25 GM059298PHS HHS A112997PHS HHS T004732
6 · The paper itself

Abstract

The human superorganism is a conglomerate of mammalian and microbial cells, with the latter estimated to outnumber the former by ten to one and the microbial genetic repertoire (microbiome) to be approximately 100-times greater than that of the human host. Given the ability of the immune response to rapidly counter infectious agents, it is striking that such a large density of microbes can exist in a state of synergy within the human host. This is particularly true of the distal gastrointestinal (GI) tract, which houses up to 1000 distinct bacterial species and an estimated excess of 1 x 10(14) microorganisms. An ever-increasing body of evidence implicates the GI microbiota in defining states of health and disease. Here, we review the literature in adult and pediatric GI microbiome studies, the emerging links between microbial community structure, function, infection and disease, and the approaches to manipulate this crucial ecosystem to improve host health.

Indexed as

Anti-Bacterial AgentsDietFoodGastrointestinal TractHumansImmunity, InnateAnti-Bacterial Agents

Identifiers

PMID20377338
PMCPMC2881665
OpenAlexW1966641706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.